SEC Form 4 · accession 0001140361-16-085748
NEVRO CORP · NVRO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Michael F Demane
Director
Period of report
Nov 8, 2016
Accepted (ET)
Nov 10, 2016 · 12:46 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001444380
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Nov 8, 2016 | M | 30,000 | $3.60 | A | 515,920 | D | |
| Common StockF1 | holding | — | — | — | 72,554 | I | See footnote | |
| Common StockF2 | holding | — | — | — | 4,255 | I | See footnote |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F3 | $3.60 | Nov 8, 2016 | M | 30,000 | D | — | May 14, 2023 | Common Stock | 30,000 | 64,501 | D |
Explanation of responses
- F1Shares held by Catherine Q. DeMane Trustee, Michael F. DeMane 2012 Irrevocable Trust U/A/D July 26, 2012.
- F2Shares held by The Michael F. DeMane 2013 Retained Annuity Trust.
- F31/48th of the shares subject to the option vest on each monthly anniversary measured from May 15, 2013 (the "Vesting Commencement Date"), such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date.